FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

38625711000001103: Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1388581000001117 Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1388591000001115 Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Is a Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible tablet (clinical drug) false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Is a Ondansetron 4mg orodispersible tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) 10 tablet Has AMP True Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start